000 01637 a2200421 4500
005 20250516213208.0
264 0 _c20150527
008 201505s 0 0 eng d
022 _a1439-3646
024 7 _a10.1055/s-0034-1374610
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKerschan-Schindl, K
245 0 0 _aCurrent controversies in clinical management of postmenopausal osteoporosis.
_h[electronic resource]
260 _bExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
_cSep 2014
300 _a437-44 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Density Conservation Agents
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOsteoporosis, Postmenopausal
_xcomplications
650 0 4 _aOsteoporotic Fractures
_xetiology
650 0 4 _aPatient Compliance
650 0 4 _aRisk Assessment
700 1 _aMikosch, P
700 1 _aObermayer-Pietsch, B
700 1 _aGasser, R W
700 1 _aDimai, H-P
700 1 _aFahrleitner-Pammer, A
700 1 _aDobnig, H
700 1 _aRoschger, P
700 1 _aPreisinger, E
700 1 _aKlaushofer, K
700 1 _aResch, H
700 1 _aPietschmann, P
773 0 _tExperimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
_gvol. 122
_gno. 8
_gp. 437-44
856 4 0 _uhttps://doi.org/10.1055/s-0034-1374610
_zAvailable from publisher's website
999 _c23834983
_d23834983